Genitourinary Medical Oncologist/Oncology Research Director
START Center for Cancer Research
Genitourinary Medical Oncologist/Oncology Research Director
START Center for Cancer Research
Phase 1 cancer trials with genomic profiling
The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval.
We are seeking a Genitourinary (GU) Physician Investigator (PI).
The Genitourinary (GU) Physician Investigator (PI) is a physician-scientist with demonstrated clinical research team leadership skills responsible for the overall preparation, conduct, and management of GU Oncology clinical trials including Phase 1 studies. This role will manage the development and execution of clinical trial protocols, contribute to data analysis, and maintain strong communication and alignment with industry sponsors while maintaining compliance with all regulatory requirements and institutional policies.
Essential Responsibilities:
Required Education and Experience:
Preferred Education and Experience:
Travel Requirements
Potential applicants should directly contact Mary Vidovich ([email protected]) or Chris H. Takimoto, MD, PhD ([email protected]) at START Research
Ready to be part of a team changing the future of cancer treatment?
Join us in our mission to conquer cancer, one clinical trial at a time. Your expertise and dedication can help us bring hope and healing to patients worldwide.
We are an equal opportunity employer that welcomes and encourages diversity in the workplace. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Phase 1 cancer trials with genomic profiling
START Center for Cancer Research runs Phase 1 clinical trials for novel anti-cancer therapies through a network of research sites in the United States, Spain, Portugal, and Ireland. It connects patients with early-stage trials, supported by genetic tumor profiling, multi-disciplinary care, and state-of-the-art treatment technology, to test new drugs before they reach broader use. The center distinguishes itself by its large, community-based trial network with 40+ principal investigators and a track record of conducting over 1,500 early-phase trials, including 50 therapies that later gained FDA/EMA approval. Its goal is to speed the translation of clinical research into available treatments and to expand access to innovative options for patients and physicians worldwide.
Explore more opportunities at START Center for Cancer Research